G. Dorsey

发表

Frequency‐swept HMQC sequences for high‐throughput NMR analysis

T. Spitzer, R. D. Rutkowske, G. Dorsey, 2008, Magnetic resonance in chemistry : MRC.

Relating the structure, activity, and physical properties of ultrashort-acting benzodiazepine receptor agonists.

J. Stafford, G. J. Pacofsky, P. Feldman, 2002, Bioorganic & medicinal chemistry letters.

Identification and structure-activity studies of novel ultrashort-acting benzodiazepine receptor agonists.

J. Stafford, G. J. Pacofsky, P. Feldman, 2002, Bioorganic & medicinal chemistry letters.

6-Azasteroids: structure-activity relationships for inhibition of type 1 and 2 human 5 alpha-reductase and human adrenal 3 beta-hydroxy-delta 5-steroid dehydrogenase/3-keto-delta 5-steroid isomerase.

J. A. Ray, S. Frye, R. Mook, 1994, Journal of medicinal chemistry.

The Possibility of a Cyclic Mechanism for Acid-Catalyzed Ester Hydrolysis

M. Cheung, C. A. Lane, G. Dorsey, 1964 .

Mutagenicity of 4,4′-MethyIenedianiline Derivatives in the Salmonella histidine reversion assay

J. Epler, T. K. Rao, G. Dorsey, 1982, Archives of Toxicology.

6-Azasteroids: potent dual inhibitors of human type 1 and 2 steroid 5 alpha-reductase.

S. Frye, R. Mook, P. Maloney, 1993, Journal of medicinal chemistry.

6-Azasteroids: Potent Dual Inhibitors of Human Type 1 and 2 Steroid 5. alpha.-Reductase.

M. K. James, S. Frye, T. Tippin, 1994 .

4,4-Disubstituted cyclohexylamine based CCR5 chemokine receptor antagonists as anti-HIV-1 agents.

W. Kazmierski, R. Ferris, Maosheng Duan, 2009, Bioorganic & medicinal chemistry letters.

Electron beam curing of epoxy resins by cationic polymerization

V. Lopata, C. Janke, G. F. Dorsey, 1995 .

Structure-activity relationships for inhibition of type 1 and 2 human 5 alpha-reductase and human adrenal 3 beta-hydroxy-delta 5-steroid dehydrogenase/3-keto-delta 5-steroid isomerase by 6-azaandrost-4-en-3-ones: optimization of the C17 substituent.

S. Frye, P. Maloney, S V Frye, 1995, Journal of medicinal chemistry.